Medidata Solutions Inc. (MDSO)

80.25
2.10 2.60
NASDAQ : Technology Services
Prev Close 82.39
Open 81.96
Day Low/High 79.93 / 82.12
52 Wk Low/High 59.60 / 85.92
Volume 278.31K
Avg Volume 609.50K
Exchange NASDAQ
Shares Outstanding 59.22M
Market Cap 4.96B
EPS 0.80
P/E Ratio 113.08
Div & Yield N.A. (N.A)
Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to...

Medidata Schedules Fourth Quarter Earnings Conference Call For February 8, 2018

Medidata Schedules Fourth Quarter Earnings Conference Call For February 8, 2018

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its fourth quarter 2017 financial results before the open of the...

Qlik Announces New CEO

Qlik Announces New CEO

Qlik®, a leader in data analytics, today announced that its board appointed Mike Capone, former COO of Medidata Solutions (NASDAQ:MDSO), as Qlik's new CEO.

Medical Research Collaborating Center Selects Medidata To Meet Global Regulatory Requirements During Clinical Trials

Medical Research Collaborating Center Selects Medidata To Meet Global Regulatory Requirements During Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the Medical Research Collaborating Center (MRCC), one of the leading research...

Medidata To Present At J.P. Morgan 36th Annual Healthcare Conference

Medidata To Present At J.P. Morgan 36th Annual Healthcare Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the J.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ENTL, SCHL, WILC Downgrades: BLL, DLTH, INTL, MDSO, NTLA, PNR Initiations: PVAC Read on to get TheStreet Quant Ratings' detailed report:

New Quartesian Agreement With Medidata Expands Sponsor Access To The Medidata Clinical Cloud® During Clinical Trials

New Quartesian Agreement With Medidata Expands Sponsor Access To The Medidata Clinical Cloud® During Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, announced that Quartesian, a leading data clinical research organization (CRO), has signed a new...

Medidata Solutions Stock Sees Short Interest Move 11% Higher

Medidata Solutions Stock Sees Short Interest Move 11% Higher

The most recent short interest data has been released for the 11/30/2017 settlement date, which shows a 609,963 share increase in total short interest for Medidata Solutions, Inc. , to 6,107,996, an increase of 11.09% since 11/15/2017.

Medidata SCA Wins Scrip Award For Best Technological Development In Clinical Trials - Sponsor Focused

Medidata SCA Wins Scrip Award For Best Technological Development In Clinical Trials - Sponsor Focused

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that the Medidata Synthetic Control Arm (SCA) was recognized at the 2017 Scrip...

Medidata Expands Partnership With CytomX Therapeutics To Centralize Management Of Regulated And Nonregulated Content

Medidata Expands Partnership With CytomX Therapeutics To Centralize Management Of Regulated And Nonregulated Content

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that CytomX Therapeutics, Inc.

Industry Survey Reveals Top 14 Technologies Necessary For A Unified EClinical Platform

Industry Survey Reveals Top 14 Technologies Necessary For A Unified EClinical Platform

Running a successful clinical trial or study is a complex and highly regulated process that requires vast operational expertise, a unified eClinical platform, and advanced statistical analytics.

Medidata Presenting At The 2017 Partnerships In Clinical Trials Europe Conference

Medidata Presenting At The 2017 Partnerships In Clinical Trials Europe Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Anthony Costello, vice president of mobile health, and Michael Hughes, lead product...

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the company's participation in the 29 th Annual Piper Jaffray Healthcare...

Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research With Multi-Year Medidata ETMF Agreement

Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research With Multi-Year Medidata ETMF Agreement

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that MEL MEDICAL Enterprises, has selected Medidata eTMF to carefully and...

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON (NASDAQ: ICLR), a global provider of drug development solutions and services to the...

Medidata Honors 2017 Architects Of Hope Award Winners At Medidata NEXT Global

Medidata Honors 2017 Architects Of Hope Award Winners At Medidata NEXT Global

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the winners of the second annual Architects of Hope Awards.

Medidata Introduces New Strategic Monitoring Suite To Ensure Sponsors And Sites Meet ICH E6 Guidelines

Medidata Introduces New Strategic Monitoring Suite To Ensure Sponsors And Sites Meet ICH E6 Guidelines

Sites, Sponsors and CROs are facing increased costs and regulations in the area of monitoring.

Medidata To Host Financial Analyst Day On November 9 In New York City

Medidata To Host Financial Analyst Day On November 9 In New York City

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will host a Financial Analyst Day on Thursday, November 9, 2017 in New York...

Akros Pharma Inc. And Medidata Commemorate 10-year Partnership With Platform Expansion Agreement

Akros Pharma Inc. And Medidata Commemorate 10-year Partnership With Platform Expansion Agreement

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced today that Akros Pharma Inc.

Medidata Reports Record Third Quarter 2017 Results

Medidata Reports Record Third Quarter 2017 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced its financial results for the third quarter of 2017.

Horizon Pharma Plc To Leverage Medidata Clinical Cloud® And ETMF Solutions To Support Its Business Transformation

Horizon Pharma Plc To Leverage Medidata Clinical Cloud® And ETMF Solutions To Support Its Business Transformation

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Horizon Pharma plc (NASDAQ: HZNP) has selected the Medidata Clinical Cloud®...

Medidata Selected For Inaugural Fortune Future 50 List

Medidata Selected For Inaugural Fortune Future 50 List

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has been selected for the Fortune Future 50 list; a ranking celebrating the...

Medidata Schedules Third Quarter Earnings Conference Call For October 26, 2017

Medidata Schedules Third Quarter Earnings Conference Call For October 26, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its third quarter 2017 financial results before the open of the...

Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use Of Medidata Clinical Cloud® With Multi-Year Partnership

Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use Of Medidata Clinical Cloud® With Multi-Year Partnership

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that pharmaceutical firm H.

Industry Leaders Gather At Medidata NEXT Global 2017 To Discuss How Technology Is Transforming Clinical Research

Industry Leaders Gather At Medidata NEXT Global 2017 To Discuss How Technology Is Transforming Clinical Research

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Medidata NEXT Global will take place in New York, at Spring Studios from...

Medidata Opens New, Larger London EMEA Headquarters

Medidata Opens New, Larger London EMEA Headquarters

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the official opening of its new EMEA headquarters at 12 Hammersmith Grove, London, to...

Medidata To Present At Citi 2017 Global Technology Conference

Medidata To Present At Citi 2017 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial...

Medidata's Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People

Medidata's Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow, executive vice president and chief technology officer, has...

Fosun Pharma Selects Medidata's Unified Platform For Clinical Development In China

Fosun Pharma Selects Medidata's Unified Platform For Clinical Development In China

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced an enterprise agreement with leading Chinese healthcare group, Shanghai Fosun...

Short Interest In Medidata Solutions Moves 12.8% Lower

Short Interest In Medidata Solutions Moves 12.8% Lower

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 509,623 share decrease in total short interest for Medidata Solutions, Inc. , to 3,481,339, a decrease of 12.77% since 07/14/2017.

TheStreet Quant Rating: B (Buy)